Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30,327Revenue $M9,990Net Margin (%)1.0Altman Z-Score0.7
Enterprise Value $M61,477EPS $1.8Operating Margin %17.3Piotroski F-Score6
P/E(ttm)59.4Beneish M-Score-2.1Pre-tax Margin (%)1.1Higher ROA y-yN
Price/Book5.010-y EBITDA Growth Rate %10.5Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %55.9Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow16.5y-y EBITDA Growth Rate %36.3ROA % (ttm)0.2Higher Current Ratio y-yY
Dividend Yield %--PEG1.2ROE % (ttm)1.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M343ROIC % (ttm)-13.3Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXLou Simpson 2015-12-31 Add2.51%$70.32 - $182.32
($111.15)
$ 88.39-20%Add 38.18%2,698,614
VRXChris Davis 2015-12-31 Add0.97%$70.32 - $182.32
($111.15)
$ 88.39-20%Add 150.74%3,784,012
VRXPrivate Capital 2015-12-31 Add0.5%$70.32 - $182.32
($111.15)
$ 88.39-20%Add 13.26%336,306
VRXFirst Eagle Investment 2015-12-31 Add0.15%$70.32 - $182.32
($111.15)
$ 88.39-20%Add 55.41%1,640,132
VRXKen Fisher 2015-12-31 Sold Out $70.32 - $182.32
($111.48)
$ 88.39-21%Sold Out0
VRXLeon Cooperman 2015-09-30 Buy 1.75%$158.08 - $262.52
($233.19)
$ 88.39-62%New holding484,915
VRXSteve Mandel 2015-09-30 Add1.62%$158.08 - $262.52
($233.19)
$ 88.39-62%Add 40.52%7,461,780
VRXLou Simpson 2015-09-30 Add1.35%$158.08 - $262.52
($233.19)
$ 88.39-62%Add 13.00%1,952,983
VRXGlenn Greenberg 2015-09-30 Reduce-0.79%$158.08 - $262.52
($233.19)
$ 88.39-62%Reduce -2.16%5,577,892
VRXWallace Weitz 2015-09-30 Reduce-0.54%$158.08 - $262.52
($233.19)
$ 88.39-62%Reduce -12.08%630,155
VRXChris Davis 2015-09-30 Reduce-0.2%$158.08 - $262.52
($233.19)
$ 88.39-62%Reduce -14.36%1,509,122
VRXPrivate Capital 2015-09-30 Reduce-0.14%$158.08 - $262.52
($233.19)
$ 88.39-62%Reduce -1.91%296,931
VRXJohn Paulson 2015-09-30 Reduce-0.12%$158.08 - $262.52
($233.19)
$ 88.39-62%Reduce -1.22%8,890,000
VRXJoel Greenblatt 2015-09-30 Add0.05%$158.08 - $262.52
($233.19)
$ 88.39-62%Add 44.95%88,677
VRXRuane Cunniff 2015-09-30 Add0.03%$158.08 - $262.52
($233.19)
$ 88.39-62%Add 0.11%33,922,192
VRXGeorge Soros 2015-09-30 Sold Out -0.02%$158.08 - $262.52
($233.19)
$ 88.39-62%Sold Out0
VRXKen Fisher 2015-09-30 Add$158.08 - $262.52
($233.19)
$ 88.39-62%Add 0.27%1,833
VRXJohn Paulson 2015-06-30 Add7.33%$197.39 - $241.73
($221.34)
$ 88.39-60%Add 339.02%9,000,000
VRXLou Simpson 2015-06-30 Reduce-1.16%$197.39 - $241.73
($221.34)
$ 88.39-60%Reduce -8.97%1,728,265
VRXWallace Weitz 2015-06-30 Reduce-1.08%$197.39 - $241.73
($221.34)
$ 88.39-60%Reduce -21.86%716,730
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.4812.63view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-51.33view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-59.82view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-60.71view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-65.24view
Rosiello Robert L.Executive Vice President 2015-06-12Buy12,900$232.51-61.98view
UBBEN JEFFREY W 2015-06-10Sell4,200,000$220.24-59.87view
Farmer Ronald HaroldDirector 2015-06-09Buy1,000$260.63-66.09view
Mirovsky PavelEVP, Pres. & GM Valeant EMENA 2015-06-02Sell38,000$238.01-62.86view
Whitaker Anne ClemDirector 2015-05-26Buy7,500$234.67-62.33view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
Bill Ackman Reports Taking 19% Stake in Euro Food Company Nomad in December Feb 12 2016 
Munger on IBM, Life Advice, Why Valeant Comments Brought 'Nothing But Trouble' Feb 12 2016 
In Vast Difference From Berkshire Style, Lou Simpson Adds to Valeant Position Feb 08 2016 
Lou Simpson Adds to Valeant Stake Feb 07 2016 
So, Bill Ackman Makes Some Good Points on the Index Bubble… Feb 05 2016 
Valeant's Share Price Continues to Decline Feb 05 2016 
Whitney Tilson's New Emails to Partners Feb 05 2016 
Leith Wheeler Investment Funds 4th Quarter Review Jan 29 2016 
Pershing Square's New Presentation, Part 1 Jan 29 2016 
Steven Romick Reduces 7 Stakes in 4th Quarter Jan 28 2016 

More From Other Websites
3 Volatile U.S. Industries to Exploit in 2016 (VRX, IBB) Feb 13 2016
Express Scripts Giving 'Extra Scrutiny' to Valeant Prescriptions Feb 12 2016
Munger on IBM, Life Advice, Why Valeant Comments Brought 'Nothing But Trouble' Feb 12 2016
A gold pile-on is coming, and nine other money stories you may have missed Feb 12 2016
Five Foreign Stocks Hedge Funds Love Feb 12 2016
Charlie Munger At The 2016 Daily Journal Corporation Meeting [FULL NOTES AND AUDIO] Feb 12 2016
Inside the M&A Deals in the Health-Care Sector Feb 12 2016
How Hedge Fund Crowding Dragged Down Tableau Software Feb 12 2016
Valeant uses rare accounting maneuver for acquisitions that cushions income Feb 12 2016
Morgan Stanley is Wrong: This Biotech is Ready to Explode Higher Feb 11 2016
One Reason Why Valeant (VRX) Stock Is Retreating Today Feb 11 2016
Why You Are a Better Investor Than Bill Ackman Feb 11 2016
Valeant Pharmaceuticals Extends Recent Slide Feb 11 2016
How Hedge Fund Crowding Dragged Down Transdigm Feb 11 2016
Bill Ackman’s Pershing Square slides 8.2% in February Feb 10 2016
Bill Ackman's Pershing Square falls 8.2% in February Feb 10 2016
Bill Ackman is getting annihilated Feb 10 2016
Bill Ackman's 2 Best Investments (GGP, CP) Feb 10 2016
Munger Says Couldn't Resist Valeant Critique That Caused Trouble Feb 10 2016
[$$] Three Best Buys in Specialty Pharma Feb 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK